No Photo Available

Last Update

2016-04-23T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Michael Mulholland?

Mr. Michael S. Mulholland

Chief Executive Officer

PainReform Ltd

Direct Phone: (610) ***-****       

Email: m***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

PainReform Ltd

5 Great Valley Parkway

Malvern, Pennsylvania 19355

United States

Company Description

Established in 2007, PainReform is a venture capital backed, specialty pharmaceutical company with headquarters in Herzeliya. PainReform primarily focuses on developing reformulation of established pain therapeutics PainReform applies it propriety formula ... more

Find other employees at this company (3)

Background Information

Employment History

Senior Vice President, General Manager, US Pharmaceuticals

Cephalon , Inc.

Global Vice President, Neuroscience Marketing and Head of Sales and Marketing

Wyeth

Contributor

PR Newswire

Education

MBA

Johnson Graduate School of Management at Cornell University

Web References (18 Total References)


PainReform - Management Team

www.painreform.com [cached]

Michael S. Mulholland

Chief Executive Officer
Michael Mulholland brings over 20 years of experience in pharmaceutical marketing, sales, life cycle management and product and business development. He has successfully commercialized products and built businesses in both the US and Europe and has held significant leadership roles as an executive and general manager.
Mr. Mulholland was Senior Vice President and General Manager of Cephalon's US pharmaceutical business which is comprised of over 800 employees, spans CNS, pain and oncology and generates annual revenues in excess of $2 billion. In this role he spearheaded numerous product acquisitions, launches and partnerships which lead to top line growth of $1 billion over just four years.
Prior to joining Cephalon, Mr. Mulholland held various leadership roles at Wyeth including Global Vice President, Neuroscience Marketing and Head of Sales and Marketing in their UK affiliate which was Wyeth's largest ex-US operation. In the UK he was responsible for all commercial activities for a product portfolio spanning CNS, gastroenterology and Women's Health Care and generating $800 million in annual sales.
Earlier in his career Mr. Mulholland held roles of increasing responsibility in both sales and marketing at Pfizer, Bristol -Myers Squibb and Pharmacia where he had a consistent record of building high performance teams and delivering strong operating results.
Mr. Mulholland holds an MBA from the Johnson Graduate School of Management at Cornell University and sits on the Board of Advisors to the Fordham School of Business.
...
Michael S. Mulholland


PainReform - Management Team

www.painreform.com [cached]

Michael S. Mulholland

Chief Executive Officer
Michael Mulholland brings over 20 years of experience in pharmaceutical marketing, sales, life cycle management and product and business development. He has successfully commercialized products and built businesses in both the US and Europe and has held significant leadership roles as an executive and general manager.
Mr. Mulholland was Senior Vice President and General Manager of Cephalon's US pharmaceutical business which is comprised of over 800 employees, spans CNS, pain and oncology and generates annual revenues in excess of $2 billion. In this role he spearheaded numerous product acquisitions, launches and partnerships which lead to top line growth of $1 billion over just four years.
Prior to joining Cephalon, Mr. Mulholland held various leadership roles at Wyeth including Global Vice President, Neuroscience Marketing and Head of Sales and Marketing in their UK affiliate which was Wyeth's largest ex-US operation. In the UK he was responsible for all commercial activities for a product portfolio spanning CNS, gastroenterology and Women's Health Care and generating $800 million in annual sales.
Earlier in his career Mr. Mulholland held roles of increasing responsibility in both sales and marketing at Pfizer, Bristol -Myers Squibb and Pharmacia where he had a consistent record of building high performance teams and delivering strong operating results.
Mr. Mulholland holds an MBA from the Johnson Graduate School of Management at Cornell University and sits on the Board of Advisors to the Fordham School of Business.
...
Michael S. Mulholland


PEMSS 2007 Speakers

www.pharmexecsummit.com [cached]

Mike Mulholland, Vice President, US Pharmaceutical Operations, Cephalon


Michael S. Mulholland, ...

www.prnewswire.com [cached]

Michael S. Mulholland, Senior Vice President, U.S. Pharmaceutical Operations at Cephalon, Inc.


inVentiv Health - Newsroom - Press Releases

www.ventive.com [cached]

"inVentiv has an impressive track record and they've demonstrated a great willingness to work with us to help us achieve our goals," said Michael S. Mulholland, Senior Vice President, U.S. Pharmaceutical Operations at Cephalon, Inc.

Similar Profiles

Other People with this Name

Other people with the name Mulholland

Beverley Mulholland
Coughlan Lewis Ltd

Kate Mulholland
FTI Consulting Inc

Kandace Mulholland
Pfizer Inc

Gary Mulholland
GM Clinical Trials Consultancy Pty Ltd

Mark Mulholland
DFDS Seaways Ltd

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory